Intelligent Bio Solutions (NASDAQ: INBS) reported Q4 2023 earnings per share (EPS) of -$2.07, up 62.77% year over year. Total Intelligent Bio Solutions earnings for the quarter were -$1.97 million. In the same quarter last year, Intelligent Bio Solutions's earnings per share (EPS) was -$5.56.
As of Q2 2024, Intelligent Bio Solutions's earnings has grown year over year. Intelligent Bio Solutions's earnings in the past year totalled -$13.40 million.
What was INBS's revenue last quarter?
Intelligent Bio Solutions (NASDAQ: INBS) reported Q4 2023 revenue of $917.27 thousand up 46.46% year over year. In the same quarter last year, Intelligent Bio Solutions's revenue was $626.30 thousand.
What was INBS's revenue growth in the past year?
As of Q2 2024, Intelligent Bio Solutions's revenue has grown 140.61% year over year. This is 131.15 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Intelligent Bio Solutions's revenue in the past year totalled $2.88 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.